Prevalence and Antimicrobial Resistance Patterns of <i>Shigella</i> in Ethiopia from 2000 to 2018: A Critical Review

Samuel Chane Teferi

doi:doi:10.11648/j.cbe.20200502.12

| Peer-Reviewed

Prevalence and Antimicrobial Resistance Patterns of Shigella in Ethiopia from 2000 to 2018: A Critical Review

Samuel Chane Teferi

Published in Chemical and Biomolecular Engineering (Volume 5, Issue 2)

Received: 28 August 2020 Accepted: 14 September 2020 Published: 24 September 2020

Views: Downloads:

Download PDF

Share This Article

Twitter
Linked In
Facebook

Abstract

Shigella is a non-motile, rod shaped, nonspore forming, and non-lactose fermenting facultative anaerobic Gram-negative bacterium that causes bacillary dysentery or also known as shigellosis. It is endemic throughout the world and it is among the most common causes of bacterial diarrheal diseases. Globally, it is estimated that shigellosis causes about 1,100,000 deaths per year, two-thirds of the patients being children under 5 years of age. The disease is transmitted faeco-orally, the commonest modes being person-to-person contact and contaminated food and water. It is a disease of overcrowding, insanitary conditions and poor personal hygiene, and affects mostly children of developing countries like Ethiopia. The treatment of shigellosis has currently become more challenging due to the emergence of drug resistant species and associated with a variety. of biological, pharmacological and societal variables with the worst combinations in low and middle income countries. Multidrug-resistant Shigella significantly varies from area to area of the world in relation with the practice of widespread use of antimicrobial agents. This review paper indicates isolation of Shigella infection increases time to time from under five children to hospitalized patients and also Shigella is becoming resistance to the commonly prescribed antimicrobial drugs in Ethiopia like ampicillin, Amoxicillin, chloramphenicol and tetracycline because of misuse of antimicrobials. Therefore, performing drug susceptibility test for each shigellosis case and creating awareness about the transmission, risk factors of shigellosis for the community is invaluable.

Published in	Chemical and Biomolecular Engineering (Volume 5, Issue 2)
DOI	10.11648/j.cbe.20200502.12
Page(s)	51-56
Creative Commons	This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.
Copyright	Copyright © The Author(s), 2020. Published by Science Publishing Group

Keywords

Shigella, Ethiopia, Antimicrobial Resistance, Community

References

[1]	RJ. Al-Haddad, “Incidence of enteric pathogens causing community gastroenteritis among Kindergarten children in Gaza Governorate. Al-Azhar University–Gaza,” pp. 1-85, 2011.
[2]	SK. Niyogi, “Shigellosis,” Journal of Microbiology, vol. 43, pp. 133 43, 2005. Available at: http://www.msk.or.kr/jsp/downloadPDF1.jsp?fileName=p.133-1430.pdf.
[3]	K. MoezArdalan, MR. Zali, MM. Dallal, MR. Hemami and S. Salmanzadeh-Ahrabi, “Prevalence and pattern of antimicrobial resistance of Shigella species among patients with acute diarrhea in Karaj, Tehran, Iran,” Journal of Health Population and Nutrition, vol. 21, no. 2, pp. 96-102, 2003.
[4]	DT. Sur, J. Ramamurthy, Deen and SK Bhattacharya, “Shigellosis: challenge and management issues,” Indian Journal of Medical Research, vol. 120, no. 5, pp.454-62, 2004.
[5]	S. Bhattacharya, B. Khanal, NR. Bhattarai and ML Das, “Prevalence of Shigella species and their antimicrobial resistance patterns in eastern Nepal,” Journal of Health Population and Nutrition, vol. 23, pp. 339-42, 2005.
[6]	Center of disease control and prevention, Shigellosis: General Information NCZVED Available online at http://www.cdc.gov/nczved/divisions/dfbmd/diseases/shigellosis/, 2013.
[7]	EW. Washington, GW. Procop, PC. Schreckenberger and GL. Woods, “Colour Atlas and Textbook of Diagnostic Microbiology, 6th ed. Lippincott-Williams Publishers,” 2006.
[8]	K. Todar, “Shigella and shigellosis. Todar’s Online Textbook of Bacteriology,” 2010. Available online: http://www.textbookofbacteriology.net/Shigella.html.
[9]	K. Ray, B. Marteyn, PJ. Sansonetti and CM Tang, “Life on the inside: the intracellular lifestyle of cytosolic bacteria,” Nature Reviews Microbiology, vol. 7, no.5, pp.333–340, 2009.
[10]	P. Winkler, D. Ghadimi, J. Schrezenmeir and K. Jean-Pierre, “Molecular and Cellular Basis of Microflora-Host Interactions,” Journal of Nutrition, vol. 137, no. 8, pp. 756S–772, 2007.
[11]	S. Romero, G. Grompone, N. Carayol et al., “ATP-Mediated Erk1/2 Activation Stimulates Bacterial Capture by Filopodia, which Precedes Shigella Invasion of Epithelial Cells,” Cell Host Microbe, vol. 9, no.6, pp.508–519, 2011.
[12]	PK. Ram, JA. Crump, SK. Gupta, MA. Miller and ED. Mintz, “Analysis of data gaps pertaining to Shigella infections in low and medium human development index countries, 1984–2005Epidemiology and Infection, part II,” vol. 136, no.5, pp. 577–603, 2008.
[13]	I. Mandomando, B. Sigauque and X. Valles, “Epidemiology and clinical presentation of Shigellosis in children less than five years of age in rural Mozambique,” Pediatric Infectious Diseases Journal, vol. 26, no. 1, Article ID 1059 1061, 2007.
[14]	UNICEF/WHO, “Diarrhoea: why children are still dying and what can be done, Geneva,” 2009.
[15]	M. Woolhouse, C. Waugh, MR. Perry and H. Nair, “Global disease burden due to antibiotic resistance–state of the evidence,” Journal of Global Health, vol. 6, no.1, Article ID 010306, 2016.
[16]	KS. Sarkar, SK. Ghosh, Niyogi and SK. Bhattacharya, “Shigella dysenteriae type 1 with reduced susceptibility to fluoroquinolones,” Lancet, vol. 36, no.785, 2003.
[17]	JT. Brooks, JB. Ochieng, L. Kumar, G. Okoth, RL. Shapiro and JH. Wells, “Surveillance for bacterial diarrhea and antimicrobial resistance in rural western Kenya,” Clinical Infectious Disease, vol. 43, pp. 393-401, 2006.
[18]	A. Assefa and M. Girma, “Prevalence and antimicrobial susceptibility patterns of Salmonella and Shigella isolates among children aged below five years with diarrhea attending Robe General Hospital and Goba Referral Hospital, South East Ethiopia,” Tropical Diseases, Travel Medicine and Vaccines, vol. 5, no. 19, 2019.
[19]	AG. Kahsay and Z. Teklemariam, “Prevalence of Shigella among diarrheic children under-5 years of age attending at Mekelle health center, north Ethiopia,” BMC Res Notes, vol. 8, no. 1, pp. 788, 2015.
[20]	B. Andualem, A. Kassu, E. Diro, F. Moges and M. Gedefaw, “The prevalence and antimicrobial responses of Shigella isolates in HIV-1 infected and uninfected adult diarrhoea patients in North West Ethiopia,” Ethiopian Journal of Health Development, vol. 20, no. 2, pp. 99–105, 2006.
[21]	G. Gebreegziabher, D. Asrat, Y. W/Amanuel and T. Hagos, “Isolation and antimicrobial susceptibility profile of Shigella and Salmonella species from children with acute diarrhoea in Mekelle Hospital and Semen Health Center, Ethiopia,” Ethiopian Journal of Health Science, vol. 28, no. 2, pp. 197–206, 2018.
[22]	G. Mengistu, G. Mulugeta, T. Lema, and A. Assefa, “Prevalence and antimicrobial susceptibility patterns of Salmonella serovars and Shigella species,” Journal of Microbial & Biochemical Technology, vol. 6, Supplement 2, Article ID Article 6, 2014.
[23]	G. Beyene and H. Tassew, “Prevalence of intestinal parasite, Shigella and Salmonella species among diarrheal children in Jimma health center, Jimma southwest Ethiopia,” Annals of Clinical Microbiology and Antimicrobials, vol. 13, pp. 1-7, 2014.
[24]	K. Huruy, A. Kassu, A. Mulu et al., “High level of antimicrobial resistance in Shigella species isolated from diarrhoeal patients in University of Gondar Teaching Hospital, Gondar, Ethiopia,” Pharmacology online, vol. 2, pp. 328–340, 2008.
[25]	M. Tiruneh, “Serodiversity and antimicrobial resistance pattern of Shigella isolates at Gondar University teaching hospital, Northwest Ethiopia,” Japanese Journal of Infectious Diseases, vol. 62, no. 62, pp. 93–97, 2009.
[26]	W. Abebe, A. Earsido, S. Taye, M. Assefa, A. Eyasu and G. Godebo, “Prevalence and antibiotic susceptibility patterns of Shigella and Salmonella among children aged below five years with Diarrhoea attending Nigist Eleni Mohammed memorial hospital, South Ethiopia,” BMC Pediatrics, vol. 18, no.241, 2018.
[27]	Y. Mamuye, G. Metaferia, A. Birhanu, K. Desta, and S. Fantaw, “Isolation and antibiotic susceptibility patterns of Shigella and Salmonella among under 5 children with acute diarrhoea: a cross-sectional study at selected public health facilities in Addis Ababa, Ethiopia,” Clinical Microbiology: Open Access, vol. 4, no. 186, 2015.
[28]	A. Mache, “Antibiotic resistance and sero-groups of shigella among pediatric outpatients in southwest Ethiopia,” East African Medical Journal, vol. 78, no. 6, 2001.
[29]	M. Getie, W. Abebe and B. Tessema, “Prevalence of enteric bacteria and their antimicrobial susceptibility patterns among food handlers in Gondar town, Northwest Ethiopia,” Antimicrobial Resistance and Infection Control, vol. 8, pp. 111, 2019.
[30]	T. A. Demissie, T. Moges, M. Feleke, M. Dagnachew, and A. Getnet, “Prevalence and antimicrobial susceptibility patterns of Shigella and Salmonella species among patients with diarrhea attending Gondar town Health Institutions, Northwest Ethiopia,” Science Journal of Public Health, vol. 2, no. 5, pp. 469– 475, 2014.
[31]	G. Yismaw, C. Negeri, and A. Kassu, “A five-year antimicrobial resistance pattern observed in Shigella species isolated from stool samples in Gondar University Hospital, northwest Ethiopia,” Ethiopian Journal of Health Development, vol. 20, no. 3, pp. 194–198, 2006.
[32]	K Huruy, A Kassu, A. Mulu et al., “Intestinal parasitosis and shigellosis among diarrheal patients in Gondar teaching hospital, northwest Ethiopia,” BMC Res Notes, vol. 4, no. 472, 2011.
[33]	A. Alex, B. Seyoum, J. Yimam, G. Andualem, S. Fiseha and V. Jean-Michel, “Antibiotic susceptibility patterns of Salmonella and Shigella isolates in Harar, Eastern Ethiopia,” Journal of Infectious Disease and Immunity, vol. 3, no. 8, pp. 134–139, 2011.
[34]	G. Debas, M. Kibret, F. Biadglegne and B. Abera, “Prevalence and antimicrobial susceptibility patterns of Shigella species at Felege Hiwot Referral Hospital, Northwest Ethiopia,” Ethiopian Medical Journal, vol. 49, no.3, pp.249–56, 2011.
[35]	M. Getamesay, B. Getenet, and Z. Ahmed, “Prevalence of Shigella, Salmonella and Cmpylobacter species and their susceptibility patters among under five children with diarrhea in Hawassa Town, South Ethiopia,” Ethiopian Journal of Health Sciences, vol. 24, no. 2, pp. 101–108, 2014.
[36]	H. Mekonnen, A. kebede, S. Menkir, “Isolation rate and drug resistance patterns of Shigella species among diarrheal patients attending at Hiwot Fana Hospital, Harar, Ethiopia,” Ethiopian Journal of Science & Technology, vol. 7, no. 1, pp. 15-25, 2014.
[37]	T. Lamboro, T. Ketema, and K. Bacha, “Prevalence and antimicrobial resistance in Salmonella and Shigella species isolated from outpatients, Jimma University Specialized Hospital, Southwest Ethiopia,” Canadian Journal of Infectious Diseases & Medical Microbiology, vol. 2016, Article ID 4210760, 8 pages, 2016.
[38]	M. Mama and G. Alemu, “Prevalence, antimicrobial susceptibility patterns and associated risk factors of Shigella and Salmonella among food handlers in Arba Minch University, South Ethiopia,” BMC Infectious Diseases, vol. 16, no. 1, p. 686, 2016.
[39]	A. Mengist, G. Mengistu and A. Reta, “Prevalence and antimicrobial susceptibility pattern of Salmonella and Shigella among food handlers in catering establishments at Debre Markos University, Northwest Ethiopia,” International Journal of Infectious Disease, Vol. 75, pp. 74–79, 2018.
[40]	A. Terfassa and M. Jida, “Prevalence and antibiotics susceptibility pattern of Salmonella and Shigella species among diarrheal patients attending Nekemte Referral Hospital, Oromia, Ethiopia,” International Journal of Microbiology, vol. 24, Article ID 921, 2018.
[41]	D. Marami, K. Hailu, and M. Tolera, “Prevalence and antimicrobial susceptibility pattern of Salmonella and Shigella species among asymptomatic food handlers working in Haramaya University cafeterias, Eastern Ethiopia,” BMC Research Notes, vol. 11, no. 1, p. 74, 2018.
[42]	H. Feleke, G. Medhin, A. Abebe, B. Beyene, H. Kloss and D. Asrat, “Enteric pathogens and associated risk factors among under-five children with and without diarrhea in Wegera District, Northwestern Ethiopia,” Pan African Medical Journal, vol. 29, no. 72, 2018.
[43]	T. Abera, E. Muktar, A. Haile and G. Garedew, “Magnitude of enteropathogens and associated factors among apparently healthy food handlers at Wolkite University Student’s Cafeteria, Southern Ethiopia,” BMC Res Notes, vol. 12, no. 567, 2019.
[44]	G. Ameya, T. Tsalla, F. Getu and E. Getu, “Antimicrobial susceptibility pattern, and associated factors of Salmonella and Shigella infections among under five children in Arba Minch, South Ethiopia,” Annals of Clinical Microbiology and Antimicrobials, vol. 17, no.1, 2018.
[45]	G. Tadesse, H. Mitiku, Z. Teklemariam, and D. Marami, “Salmonella and Shigella among asymptomatic street food vendors in the dire Dawa city, Eastern Ethiopia: prevalence, antimicrobial susceptibility pattern, and associated factors,” Environmental Health Insights, vol. 13, 2019.
[46]	B. Teshome, Z. Teklemariam, D. Admassu, D. Marami and N. Asaminew, “Salmonella and Shigella among patients with diarrhea at public health facilities in Adama, Ethiopia: Prevalence, antimicrobial susceptibility pattern, and associated factors, open access, vol. 7, pp. 1–8, 2019.
[47]	A. Alemu, M. Geta, S. Taye, S. Eshetie, and T. Engda, “Prevalence, associated risk factors and antimicrobial susceptibility patterns of Shigella infections among diarrheic pediatric population attending at Gondar town healthcare institutions, Northwest Ethiopia,” Tropical Diseases, Travel Medicine and Vaccines, Vol. 5, no. 7, 2019.

Cite This Article

Plain Text BibTeX RIS

APA Style

Samuel Chane Teferi. (2020). Prevalence and Antimicrobial Resistance Patterns of Shigella in Ethiopia from 2000 to 2018: A Critical Review. Chemical and Biomolecular Engineering, 5(2), 51-56. https://doi.org/10.11648/j.cbe.20200502.12

Copy | Download

ACS Style

Samuel Chane Teferi. Prevalence and Antimicrobial Resistance Patterns of Shigella in Ethiopia from 2000 to 2018: A Critical Review. Chem. Biomol. Eng. 2020, 5(2), 51-56. doi: 10.11648/j.cbe.20200502.12

Copy | Download

AMA Style

Samuel Chane Teferi. Prevalence and Antimicrobial Resistance Patterns of Shigella in Ethiopia from 2000 to 2018: A Critical Review. Chem Biomol Eng. 2020;5(2):51-56. doi: 10.11648/j.cbe.20200502.12

Copy | Download

@article{10.11648/j.cbe.20200502.12,
  author = {Samuel Chane Teferi},
  title = {Prevalence and Antimicrobial Resistance Patterns of Shigella in Ethiopia from 2000 to 2018: A Critical Review},
  journal = {Chemical and Biomolecular Engineering},
  volume = {5},
  number = {2},
  pages = {51-56},
  doi = {10.11648/j.cbe.20200502.12},
  url = {https://doi.org/10.11648/j.cbe.20200502.12},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.cbe.20200502.12},
  abstract = {Shigella is a non-motile, rod shaped, nonspore forming, and non-lactose fermenting facultative anaerobic Gram-negative bacterium that causes bacillary dysentery or also known as shigellosis. It is endemic throughout the world and it is among the most common causes of bacterial diarrheal diseases. Globally, it is estimated that shigellosis causes about 1,100,000 deaths per year, two-thirds of the patients being children under 5 years of age. The disease is transmitted faeco-orally, the commonest modes being person-to-person contact and contaminated food and water. It is a disease of overcrowding, insanitary conditions and poor personal hygiene, and affects mostly children of developing countries like Ethiopia. The treatment of shigellosis has currently become more challenging due to the emergence of drug resistant species and associated with a variety. of biological, pharmacological and societal variables with the worst combinations in low and middle income countries. Multidrug-resistant Shigella significantly varies from area to area of the world in relation with the practice of widespread use of antimicrobial agents. This review paper indicates isolation of Shigella infection increases time to time from under five children to hospitalized patients and also Shigella is becoming resistance to the commonly prescribed antimicrobial drugs in Ethiopia like ampicillin, Amoxicillin, chloramphenicol and tetracycline because of misuse of antimicrobials. Therefore, performing drug susceptibility test for each shigellosis case and creating awareness about the transmission, risk factors of shigellosis for the community is invaluable.},
 year = {2020}
}

Copy | Download

TY  - JOUR
T1  - Prevalence and Antimicrobial Resistance Patterns of Shigella in Ethiopia from 2000 to 2018: A Critical Review
AU  - Samuel Chane Teferi
Y1  - 2020/09/24
PY  - 2020
N1  - https://doi.org/10.11648/j.cbe.20200502.12
DO  - 10.11648/j.cbe.20200502.12
T2  - Chemical and Biomolecular Engineering
JF  - Chemical and Biomolecular Engineering
JO  - Chemical and Biomolecular Engineering
SP  - 51
EP  - 56
PB  - Science Publishing Group
SN  - 2578-8884
UR  - https://doi.org/10.11648/j.cbe.20200502.12
AB  - Shigella is a non-motile, rod shaped, nonspore forming, and non-lactose fermenting facultative anaerobic Gram-negative bacterium that causes bacillary dysentery or also known as shigellosis. It is endemic throughout the world and it is among the most common causes of bacterial diarrheal diseases. Globally, it is estimated that shigellosis causes about 1,100,000 deaths per year, two-thirds of the patients being children under 5 years of age. The disease is transmitted faeco-orally, the commonest modes being person-to-person contact and contaminated food and water. It is a disease of overcrowding, insanitary conditions and poor personal hygiene, and affects mostly children of developing countries like Ethiopia. The treatment of shigellosis has currently become more challenging due to the emergence of drug resistant species and associated with a variety. of biological, pharmacological and societal variables with the worst combinations in low and middle income countries. Multidrug-resistant Shigella significantly varies from area to area of the world in relation with the practice of widespread use of antimicrobial agents. This review paper indicates isolation of Shigella infection increases time to time from under five children to hospitalized patients and also Shigella is becoming resistance to the commonly prescribed antimicrobial drugs in Ethiopia like ampicillin, Amoxicillin, chloramphenicol and tetracycline because of misuse of antimicrobials. Therefore, performing drug susceptibility test for each shigellosis case and creating awareness about the transmission, risk factors of shigellosis for the community is invaluable.
VL  - 5
IS  - 2
ER  -

Copy | Download

Author Information

Samuel Chane Teferi

College of Natural and Computational Sciences, Department of Biology, Salale University, Fitche, Ethiopia

Download PDF

Sections

Plain Text BibTeX RIS

APA Style

Samuel Chane Teferi. (2020). Prevalence and Antimicrobial Resistance Patterns of Shigella in Ethiopia from 2000 to 2018: A Critical Review. Chemical and Biomolecular Engineering, 5(2), 51-56. https://doi.org/10.11648/j.cbe.20200502.12

Copy | Download

ACS Style

Samuel Chane Teferi. Prevalence and Antimicrobial Resistance Patterns of Shigella in Ethiopia from 2000 to 2018: A Critical Review. Chem. Biomol. Eng. 2020, 5(2), 51-56. doi: 10.11648/j.cbe.20200502.12

Copy | Download

AMA Style

Samuel Chane Teferi. Prevalence and Antimicrobial Resistance Patterns of Shigella in Ethiopia from 2000 to 2018: A Critical Review. Chem Biomol Eng. 2020;5(2):51-56. doi: 10.11648/j.cbe.20200502.12

Copy | Download

@article{10.11648/j.cbe.20200502.12,
  author = {Samuel Chane Teferi},
  title = {Prevalence and Antimicrobial Resistance Patterns of Shigella in Ethiopia from 2000 to 2018: A Critical Review},
  journal = {Chemical and Biomolecular Engineering},
  volume = {5},
  number = {2},
  pages = {51-56},
  doi = {10.11648/j.cbe.20200502.12},
  url = {https://doi.org/10.11648/j.cbe.20200502.12},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.cbe.20200502.12},
  abstract = {Shigella is a non-motile, rod shaped, nonspore forming, and non-lactose fermenting facultative anaerobic Gram-negative bacterium that causes bacillary dysentery or also known as shigellosis. It is endemic throughout the world and it is among the most common causes of bacterial diarrheal diseases. Globally, it is estimated that shigellosis causes about 1,100,000 deaths per year, two-thirds of the patients being children under 5 years of age. The disease is transmitted faeco-orally, the commonest modes being person-to-person contact and contaminated food and water. It is a disease of overcrowding, insanitary conditions and poor personal hygiene, and affects mostly children of developing countries like Ethiopia. The treatment of shigellosis has currently become more challenging due to the emergence of drug resistant species and associated with a variety. of biological, pharmacological and societal variables with the worst combinations in low and middle income countries. Multidrug-resistant Shigella significantly varies from area to area of the world in relation with the practice of widespread use of antimicrobial agents. This review paper indicates isolation of Shigella infection increases time to time from under five children to hospitalized patients and also Shigella is becoming resistance to the commonly prescribed antimicrobial drugs in Ethiopia like ampicillin, Amoxicillin, chloramphenicol and tetracycline because of misuse of antimicrobials. Therefore, performing drug susceptibility test for each shigellosis case and creating awareness about the transmission, risk factors of shigellosis for the community is invaluable.},
 year = {2020}
}

Copy | Download

TY  - JOUR
T1  - Prevalence and Antimicrobial Resistance Patterns of Shigella in Ethiopia from 2000 to 2018: A Critical Review
AU  - Samuel Chane Teferi
Y1  - 2020/09/24
PY  - 2020
N1  - https://doi.org/10.11648/j.cbe.20200502.12
DO  - 10.11648/j.cbe.20200502.12
T2  - Chemical and Biomolecular Engineering
JF  - Chemical and Biomolecular Engineering
JO  - Chemical and Biomolecular Engineering
SP  - 51
EP  - 56
PB  - Science Publishing Group
SN  - 2578-8884
UR  - https://doi.org/10.11648/j.cbe.20200502.12
AB  - Shigella is a non-motile, rod shaped, nonspore forming, and non-lactose fermenting facultative anaerobic Gram-negative bacterium that causes bacillary dysentery or also known as shigellosis. It is endemic throughout the world and it is among the most common causes of bacterial diarrheal diseases. Globally, it is estimated that shigellosis causes about 1,100,000 deaths per year, two-thirds of the patients being children under 5 years of age. The disease is transmitted faeco-orally, the commonest modes being person-to-person contact and contaminated food and water. It is a disease of overcrowding, insanitary conditions and poor personal hygiene, and affects mostly children of developing countries like Ethiopia. The treatment of shigellosis has currently become more challenging due to the emergence of drug resistant species and associated with a variety. of biological, pharmacological and societal variables with the worst combinations in low and middle income countries. Multidrug-resistant Shigella significantly varies from area to area of the world in relation with the practice of widespread use of antimicrobial agents. This review paper indicates isolation of Shigella infection increases time to time from under five children to hospitalized patients and also Shigella is becoming resistance to the commonly prescribed antimicrobial drugs in Ethiopia like ampicillin, Amoxicillin, chloramphenicol and tetracycline because of misuse of antimicrobials. Therefore, performing drug susceptibility test for each shigellosis case and creating awareness about the transmission, risk factors of shigellosis for the community is invaluable.
VL  - 5
IS  - 2
ER  -

Copy | Download